Shares of Victrex plc (LON:VCT - Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 906.39 ($12.45) and traded as low as GBX 774 ($10.63). Victrex shares last traded at GBX 776 ($10.66), with a volume of 168,587 shares changing hands.
Victrex Trading Down 2.3%
The company has a quick ratio of 1.99, a current ratio of 4.39 and a debt-to-equity ratio of 10.93. The company's fifty day moving average is GBX 806.66 and its two-hundred day moving average is GBX 906.39. The stock has a market cap of £676.92 million, a price-to-earnings ratio of 22.05, a PEG ratio of 1.92 and a beta of 0.69.
Victrex (LON:VCT - Get Free Report) last released its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. On average, research analysts predict that Victrex plc will post 73.1078905 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, insider David Thomas acquired 1,158 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average cost of GBX 846 ($11.62) per share, with a total value of £9,796.68 ($13,453.28). Insiders own 1.64% of the company's stock.
Victrex Company Profile
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
